Ajouter aux favoris   Ajouter cette page à mon bookmark --- SOCIAL BOOKMARKING --- Digg Furl del.icio.us Netscape

Introduction

Encysive Pharmaceuticals (formerly known as Texas Biotechnology) is a biopharmaceutical company focused on cardiovascular and inflammatory diseases such as: heparin-induced thrombocytopenia (HIT), pulmonary hypertension, essential hypertension, chronic heart failure, multiple sclerosis, asthma, and atherosclerosis.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis

Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors

Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Encysive is a biopharmaceutical company focused on the discovery, development and commercialization of novel, synthetic, small molecule compounds to address cardiovascular and inflammatory diseases.

The company's total revenues increased at a CAGR of 21% during 2002-2006, from $8 million to $18 million. This represents an absolute total growth of +$10 million for total revenues. The company's biggest contributor to revenue growth during 2002-2006 was royalties from sales of Argatroban.

The company's biggest contributor to sales growth out to 2010 will be the product sales of Thelin. Revenues from Thelin are expected to increase at a CAGR of 328.7%, from $0.3 million in 2006 to $108.4 million in 2010. This represents an absolute growth of +$108.1 million, which is 82% of Encysive's total forecast growth.

Reasons to Purchase

Access all the important information and analysis on the company in a single report

Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain

Gain access to company's adjusted five year financial data along with key ratios and market capitalization

TABLE OF CONTENTS
Overview 1
Catalyst 1
Summary 1
Company Structure 6
Company Overview and Key Facts 6
Business Description 7
History 8
Locations and Subsidiaries 10
Company Financials 11
Stock Market Performance 11
P&L 14
Balance Sheet 16
Cash Flow 16
Business Segment Performance 17
Geographic Segment Performance 18
Products & Services 20
Marketed Products 20
Pipeline Products 21
Historical Product Sales 22
AC Forecast Product Sales 23
Competitors and Strategic Business Relationships 25
Key Competitors 25
Key Suppliers 25
Key Clients 26
Shareholding Structure 27
Strategy 28
Company View 28
Corporate Strategy 29
SWOT Analysis 31
Overview 31
Strengths 32
Weaknesses 34
Opportunities 35
Threats 36
Value Chain Analysis 37
Overview 37
Discovery and Product Development 38
Sales 38
Scorecard 39
Overview 39
Scorecard Analysis 40
Key Employees 41
List of Key Employees 41
Key Employee Biographies 42
Financial and Operational Overview 47
Financial and Operational Overview 47
APPENDIX 50
Ask the analyst 50
Datamonitor consulting 50
Disclaimer 50


TABLE OF FIGURES
Figure 1: Encysive - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 15
Figure 2: Encysive - Key Strategic Revenues, 2002-2006 ($ Mn) 18
Figure 3: Encysive - Key Strategic Revenues, 2006-2010 ($ Mn) 24


TABLE OF TABLES
Table 1: Encysive - Key Facts 6
Table 2: Encysive – Locations and Subsidiaries 10
Table 3: Encysive - Year-End Share Price and Market Capitalization, 2002-2006 ($) 11
Table 4: Encysive - Key Events Impacting Share Price Performance 12
Table 5: Encysive - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 14
Table 6: Encysive - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 15
Table 7: Encysive - Balance Sheet, 2002-2006 ($ Mn) 16
Table 8: Encysive - Cash Flow, 2002-2006 ($ Mn) 16
Table 9: Encysive - Revenue Breakdown, 2002-2006 ($ Mn) 17
Table 10: Encysive - Geographic Breakdown, 2002-2006 ($ Mn) 19
Table 11: Encysive - Marketed Products 20
Table 12: Encysive - In-house Pipeline Products 21
Table 13: Encysive - Collaboration Products 21
Table 14: Encysive - Historical Product Sales, 2002-2006 ($ Mn) 22
Table 15: Encysive - Forecast Sales, 2006-2010 ($ Mn) 23
Table 16: Encysive - Key Competitors 25
Table 17: Encysive – Key Suppliers 25
Table 18: Encysive – Key Clients 26
Table 19: Encysive - Key Shareholders 27
Table 20: Encysive - SWOT Analysis Summary 31
Table 21: Encysive – Value Chain Analysis 37
Table 22: Encysive – Scorecard 40
Table 23: Encysive - Key Employees 41
Table 24: Encysive - Financial and Operational Overview 48